■ This newspaper news (all-media reporter Hu Dan)
On October 23 this year, at the second Green Development Young Doctorate Forum in Anji County, Zhejiang Huajun Pharmaceutical Co., Ltd. successfully introduced Dr. Li Jie of Paderborn University in Germany through the unveiling of the leader, injecting strong impetus into the company's research on the "Tumor Neoantigen Personalized Peptide Vaccine Project".
Pharmaceuticals is a long and huge project, and the demand for high-end talents has always been great. For an enterprise with more than 20 years of technical accumulation, how to find the right track and open up a new direction on the basis of the original field is a new topic for Huajun Pharmaceutical. Founded in 2015, Huajun Pharmaceutical is a wholly-owned subsidiary of Zhejiang Huadi Pharmaceutical Group Co., Ltd. In 2017, Huajun Pharmaceutical successfully declared the leading entrepreneurial team of South Taihu Lake through the project of "Construction of Demonstration Line for the Production of Peptide Biological Large Health Products", and the company further determined the goal of continuous exploration and research and development in the field of small molecule polypeptides.
Find the right track And break with tradition in your area of expertise
There are many types of peptides, while traditional peptides are converted into drugs, with long cycles, large investments, and fierce competition. "There are thousands of enterprises in China, and there are more than 20 enterprises with peptide production qualifications, and how to carry out differentiated competition is a problem we have been considering." Zhou Zhengbing, general manager of Huajun Pharmaceutical, said. As the leader of the enterprise scientific and technological innovation team, Zhou Zhengbing has been engaged in the research and research and development of animal-derived active substances and synthetic polypeptides for more than ten years, and participated in the drafting of the GMP appendix of biochemical drugs, participated in the research on improving the standards of biochemical drugs organized by the State Pharmacopoeia Commission for many times, and presided over or participated in national, provincial and municipal science and technology projects for many times. How to break through in the cutting-edge field of the industry? Zhou Zhengbing has been looking for the most suitable track for enterprises.
The research and development of tumor neoantigen personalized peptide vaccine is the development direction chosen by Huajun Pharmaceutical for itself. Compared with traditional drugs, tumor neoantigen personalized peptide vaccine is a customized product. "Most tumors, especially solid tumors, are actually human genetic mutations, and modern medicine generally uses surgery to remove solid tumors, and the removed solid tumors can find the sequence through gene sequencing, and then analyze them through bioinformatics." Through our synthetic polypeptides, they are transmitted back to the human body to stimulate the body's immune system, thereby achieving anti-tumor effects. Zhou Zhengbing said.
In the field of polypeptides, in addition to the drug peptides that convert polypeptides into drugs, there are also customer peptides that provide customized peptides for professional institutions, the former requires production capacity and qualifications, and the latter requires strong research and development capabilities, and Huajun Pharmaceutical just has the strengths of both, and this is also the advantages of Huajun Pharmaceutical industry to explore the field of tumor neogen personalized polypeptide vaccines. Parent company Huadi Pharmaceutical has obtained the GMP certificate of peptide drugs in 2007, with more than 20 years of experience in the production of peptide products, Huajun Pharmaceutical is constantly making breakthroughs in technology, has the ability to personalize the production of peptide vaccine raw materials, and cooperates with domestic frontier institutions to build an integrated advantage from production to research and development in the industry.
Attracting talents and retaining talents is the mainstay of the mainstay and the top soldiers who break the problem
Unveiling the leader allows enterprises to find the talents they desire, and also allows enterprises to add wings to the research and development of personalized peptide vaccines for tumor neogens.
In recent years, with the continuous development of biopharmaceutical technology, our company is also actively developing the international cutting-edge tumor neoantigen peptide vaccine project. The most core technical part of this project is how to design a new antigen with stronger antigenics and higher technical efficiency, this part of the technology is also the technical bottleneck that our company is currently facing, and we have been looking for talents who meet this requirement to join the enterprise to jointly develop this project Zhou Zhengbing said.
As a result, Huajun Pharmaceutical released talent needs through "unveiling the commander-in-chief", and relevant departments connected relevant talents for enterprises through multiple channels.
And Li Jie is the problem-breaking sharp soldier that the company is waiting for. "I am a native of Anji, through the introduction of the Organization Department of the county party committee and the United Front Work Department, I learned about the technical bottleneck of Huajun Pharmaceutical, it just so happens that I have been engaged in the design and development of functional molecules in the field of polymer chemistry for a long time, and have accumulated a wealth of experience in the synthesis technology of simulated peptides, the assembly regulation of functional molecules and the delivery technology of drug molecules, etc. Technologies such as the folding and encapsulation of peptide molecules and how peptide vaccines can be delivered efficiently into the human body give us the confidence and confidence to roll off the list "Li Jie's professionalism is highly compatible with the development of the enterprise. As an Anji person, Li Jie has more feelings in his heart. "As an Anji person, I have always wanted to do a little bit for the construction and development of my hometown, and being able to unveil this list is also a great opportunity for me to serve Anji enterprises."
In addition to the introduction of high-end talents, the demand for basic talents in Huajun Pharmaceutical is also very large. "Because of the particularity of the industry, our basic operation industry needs college students with professional backgrounds, so every year we will participate in the college job fair organized by the county human resources and social security bureau." Now there are more than 40 employees, half of whom are recruited in Anji, and this group of people has become the mainstay of enterprise development. "There are both crackers and mainstays. The road of Huajun Pharmaceutical's talent introduction is steadily advancing under the escort of the county party committee and county government.
【Source: Anji News】
Disclaimer: The copyright of this article belongs to the original author, if there is an error in the source or infringement of your legitimate rights and interests, you can contact us through the mailbox, we will deal with it in a timely manner. Email address: [email protected]